All articles tagged: Malignant neoplasm of rectum (C20)
Evalytics
19 March at 06.39 AM
A new way to screen for colon cancer may be on the horizon, study suggestsThe potential approval of the first blood test for colorectal cancer this year could mark a significant breakthrough in cancer detection, potentially increasing the number of diagnoses for the second-highest cause of cancer death in the United States. While experts emphasize that the test would not replace colonoscopies, it could offer a less invasive alternative and encourage more people to under |
HealthDay
11 January at 05.10 PM
Robotic Surgery Preferred for Most Colorectal Cancer SurgeriesRobotic surgery for colorectal cancer (CRC) offers an advantage over conventional laparoscopy by improving textbook outcomes for right colectomy (RC) and left colectomy (LC), according to a study recently published in the World Journal of Surgical Oncology.Emile Farah, M.D., from the University of Texas Southwestern (UTSW) Medica |
|
HealthDay
21 December at 11.08 PM
MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy CessationMost patients with microsatellite instability-high (MSI-H) colorectal cancer do not have recurrence after cessation of immunotherapy treatment, according to a study published in the December issue of Cancer Research Communications.Kristen Simmons, M.D., from the Baylor College of Medicine in Houston, and colleagues reviewed records fr |
|
Evalytics
18 December at 06.06 PM
People who got colon cancer in their 20s or 30s describe what it was like and the signs that were ignoredThe NBC News article discusses the increasing cases of colon cancer in young adults and features personal stories of individuals who faced diagnostic challenges due to their age. It underscores the need for early detection and awareness of colon cancer symptoms in younger populations. |
|
HealthDay
28 November at 05.03 PM
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III DiseaseFrom 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting of the Danish Surgical Society, held from Nov. 16 to 17 in Copenhagen.Jesper Nors, M.D., from Aarhus University Hosp |
|
HealthDay
22 November at 10.44 PM
>10 Percent of FIT Are Unsatisfactory and Cannot Be ProcessedMore than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15 months, according to a study published online Nov. 3 in Cancer Epidemiology, Biomarkers & Prevention.Po-Hong Liu, M.D., from the University of Texas Southweste |
|
|
HealthDay
07 November at 04.44 PM
Advanced Neoplasia Risk Increased at Upper Range of Negative FIT ValuesIndividuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online Nov. 7 in the Annals of Internal Medicine.Tobias Niedermaier, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues provided a dose |
|
HealthDay
30 October at 03.39 PM
Risk-Adapted Starting Age of CRC Screening Varies by Sex, GeneticsRisk-adapted starting ages of screening vary by sex and polygenic risk score (PRS) among individuals at average risk for colorectal cancer (CRC), according to a study published online Oct. 25 in JAMA Network Open.Xuechen Chen, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues illustrated derivation of risk-adju |
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
|
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
|
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
|
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
|
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
|
|
|
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
|
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
|
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
|
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
